Haemonetics Corp. (hae 0 03/01/26)

13F holders, Q1 2025 (March 31)
8holders −1
1new positions
2sold out
$0.95avg. 13F price*

At the end of Q1 2025, 8 institutions reported holding Haemonetics Corp. (hae 0 03/01/26) in their 13F filings, down 1 from Q4 2024. 1 opened new positions and 2 sold out. The largest holders were Angelo Gordon & Co., L.P. ($5.7M), BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($3.8M) and Sei Investments Co. ($320K).

Company
Haemonetics Corp. (hae 0 03/01/26)
CUSIP
405024AB6
Latest filing quarter
Q4 2025

History

Number of 13F holders

051015 Q1 2024: 7Q1 2024Q2 2024: 6Q2 2024Q3 2024: 10Q3 2024Q4 2024: 9Q4 2024Q1 2025: 8Q1 2025Q2 2025: 9Q2 2025Q3 2025: 10Q3 2025Q4 2025: 11Q4 2025

Total Exit/New Position Q4 2024 → Q1 2025

InstitutionsTotal Value
New Positions1$40K
Exits2$2.9M

All 13F filers, Q4 2024 → Q1 2025: 45,000 shares bought and 3,145,000 shares sold, net −3,100,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 8 holders

Angelo Gordon & Co., L.P. 1.21% No change 6,000,000 $5.7M
BNP PARIBAS ASSET MANAGEMENT Holding S.A. 0.01% No change 4,000,000 $3.8M
Sei Investments Co. 0.00% No change 335,000 $320K
Oppenheimer Asset Management Inc. 0.00% Add +1.1% 190,000 $181K
Stephens Inc. 0.00% Add +1.8% 57,000 $54K
Wealthspire Advisors, LLC 0.00% New 42,000 $40K
LPL Financial LLC 0.00% No change 41,000 $39K
Commonwealth Equity Services, LLC 0.00% No change 20,000 $19K

"% of holder's portfolio" is HAEMONETICS CORP (HAE 0 03/01/26)'s weight in each manager's 13F, not the share of Haemonetics Corp. (hae 0 03/01/26) the manager owns.